CLARISCAN 376.9 mg/mL (Gadoterate Meglumine INJECTION, SOLUTION) 376.9 mg/mL

Clariscan 376.9 mg/mL is a gadoterate meglumine injection solution used for magnetic resonance imaging (MRI) contrast enhancement. This intravenous solution aids in improving the visibility of internal structures during MRI scans.

Strength

376.9 mg/mL

Pack Size

10 VIAL, GLASS in 1 BOX (0407-2943-05) / 20 mL in 1 VIAL, GLASS

Manufacturer / TM Owner

GE Healthcare

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clariscan 376.9 mg/mL is primarily used as a contrast agent in MRI procedures. It helps to enhance the clarity of images, making it easier for healthcare professionals to detect and diagnose various conditions. The solution is administered intravenously and is commonly used in what is gadoterate meglumine used for, including imaging of the brain, spine, and other internal structures.

Side Effects

Common effects of Clariscan 376.9 mg/mL may include temporary discomfort at the injection site, such as redness or swelling. Some individuals might experience a warm sensation or nausea. These effects are generally mild and short-lived.

Precautions & Warnings

Clariscan 376.9 mg/mL should be handled with care, ensuring it is stored and administered under proper medical supervision. It is important to inform healthcare providers of any allergies or pre-existing conditions before use. The solution should be inspected for particles or discoloration before administration.

Avoid Interactions

Clariscan 376.9 mg/mL may interact with certain medications or medical conditions. It is advisable to discuss all current medications and health conditions with a healthcare provider before using this contrast agent. Specific interactions with alcohol or other substances should be reviewed with a medical professional.

References

Frequently Asked Questions

Clariscan 376.9 mg/mL is used as a contrast agent to enhance the visibility of internal structures during MRI scans.

Clariscan 376.9 mg/mL is administered intravenously by a healthcare professional during an MRI procedure.

Common side effects may include temporary discomfort at the injection site, such as redness or swelling, and a warm sensation or nausea.

Clariscan 376.9 mg/mL should be used under medical supervision, and it is important to inform healthcare providers of any allergies or pre-existing conditions.

Clariscan 376.9 mg/mL should be stored as per the manufacturer's instructions, typically in a cool, dry place away from direct sunlight.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.